| Financial Year |
March 31 2023 |
| Monetary Funds |
1,120,884,566.01 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,464,270,076.01 |
| Accounts Receivable |
709,535,824.21 |
| Advances to Suppliers |
342,917,184.62 |
| Other Receivables |
119,480,669.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
68,378,135.96 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
123,324,341.24 |
| Total Current Assets |
4,255,151,625.06 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
13,079,394.31 |
| Long-term Equity Investment |
121,083,695.21 |
| Investment Properties |
-- |
| Fixed Assetes |
3,899,300,917.22 |
| Under-construction Projects |
91,341,909.46 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
487,211,807.08 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
11,374,147.55 |
| Deferred Income Tax Assets |
35,568,518.44 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
4,664,778,869.89 |
| Total Assets |
8,919,930,494.95 |
| Short-Term Loans |
3,968,857,424.76 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,396,433,478.39 |
| Accounts Payable |
259,332,568.28 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
76,049,006.16 |
| Taxes Payable |
49,940,626.93 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
657,123,393.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
187,478,986.09 |
| Other Current Liabilities |
652,882,167.58 |
| Sub-Total of Current Liabilities |
7,298,563,513.39 |
| Long-term Loans |
142,900,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
748,098,049.23 |
| Special Payable |
-- |
| Estimatied Liabilities |
23,113,630.36 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,082,313,329.74 |
| Total Liabilities |
8,380,876,843.13 |
| Paid-In Capital(Or Share Stock) |
989,959,882.00 |
| Capital Surplus |
1,863,283,020.38 |
| Surplus Reserve |
239,970,946.30 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,518,595,252.79 |
| Minority Stockholder's Interest |
-107,338,991.62 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
646,392,643.44 |
| Owner's Equity（Stockholder's Equity） |
539,053,651.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,919,930,494.95 |
